1,200 results match your criteria: "Centro Hospitalar De Vila Nova De Gaia[Affiliation]"

Infectious sacroiliitis is a rare and challenging diagnosis. Sacroiliac joint changes related to pregnancy and puerperium can predispose to this condition. However, its clinical presentation can often mimic common causes of lower back pain and delay the diagnosis.

View Article and Find Full Text PDF

Chronic diarrhea is a common disorder in tropical regions, affecting residents, visitors, and even expatriates. It may stem from a myriad of infectious, inflammatory, and even malignant causes. In patients in whom no etiology has been found, tropical sprue (TS) is an important diagnosis to consider.

View Article and Find Full Text PDF

Training and attitudes concerning cardiac rehabilitation in Portugal: A national survey of physician members of the Portuguese Society of Cardiology.

Rev Port Cardiol

September 2024

Cardiology Department, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Introduction And Objectives: Cardiac rehabilitation (CR) is a central component in the management of cardiovascular disease. While its potential benefits have been extensively explored and confirmed, its implementation is still suboptimal, due to various possible barriers. This study aimed to assess training and attitudes concerning CR among physicians in a Portuguese setting.

View Article and Find Full Text PDF

Is Reducing Heart Failure Hospitalization Associated With Reducing Mortality in Heart Failure Trials?

JACC Heart Fail

April 2024

Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Cardiovascular Research and Development Center, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, Portugal; Institut National de la Santé et de la Recherche Médicale U1116, Centre Hospitalier Régional Universitaire, French Clinical Research Infrastructure Network, Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, Nancy, France.

View Article and Find Full Text PDF
Article Synopsis
  • - The document reviews recent studies and international guidelines to provide updated recommendations for internists managing acute heart failure (AHF) in complex patient scenarios.
  • - Seven key clinical questions (PICOs) were identified regarding diagnosis and treatment, emphasizing the importance of echocardiography and natriuretic peptide evaluations, along with other diagnostic tools.
  • - A total of 51 tailored recommendations were developed to address treatment strategies and improve outcomes for AHF patients, including options for managing low blood pressure and preventing rehospitalization.
View Article and Find Full Text PDF

Management of infusion-related reactions in cancer therapy: strategies and challenges.

ESMO Open

March 2024

Medical Oncology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal; Oncology Research Unit, UMIB-Unit for Multidisciplinary Research in Biomedicine, ICBAS-School of Medicine and Biomedical Sciences, Universidade do Porto, Porto, Portugal. Electronic address:

Several anticancer therapies have the potential to cause infusion-related reactions (IRRs) in the form of adverse events that typically occur within minutes to hours after drug infusion. IRRs can range in severity from mild to severe anaphylaxis-like reactions. Careful monitoring at infusion initiation, prompt recognition, and appropriate clinical assessment of the IRR and its severity, followed by immediate management, are required to ensure patient safety and optimal outcomes.

View Article and Find Full Text PDF

Coronary Artery Calcium Score Predicts Major Adverse Cardiovascular Events in Stable Chest Pain.

Radiology

March 2024

From the Department of Radiology (F.B., E.Z., A.E.N., R. Haase, S.F., M. Mohamed, M.R., V.W., M.E., M. Bosserdt, M.D.), Institute of Public Health (N.R.), Institute of Biometry and Clinical Epidemiology (K.N.), and Department of Cardiology and Angiology (H.D.), Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany; Department of Radiology, University of Cagliari, Cagliari, Italy (L.S., R.C.); Heart and Vascular Center (M. Boussoussou, P.M.H., B.M., B.S., I.F.É.) and Department of Radiology, Medical Imaging Center (P.M.H.), Semmelweis University, Budapest, Hungary; Departments of Cardiology (K.F.K., P.E.S.) and Radiology (K.F.K., P.E.S.), Copenhagen University Hospital-Rigshospitalet and Department of Clinical Medicine (J.D.H.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Internal Medicine, Clinic of Cardiology (T.B., R. Hodas), and Department of Cardiology (R.A.), George Emil Palade University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania; County Clinical Emergency Hospital Targu Mures, Targu Mures, Romania (T.B.); Department of Cardiology, Southeastern Health and Social Care Trust, Belfast, United Kingdom (P.D., C.O., S.K., S.R.); Departments of Cardiology (J.R.P., F.X.V., B.G.d.B.) and Radiology (H.C.C.), Hospital Universitario Vall d'Hebron, Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red, Madrid, Spain (J.R.P., F.X.V., B.G.d.B.); Departments of Cardiology (A.E.) and Radiology (L.Z.), Paul Stradins Clinical University Hospital, Riga, Latvia; University of Latvia, Riga, Latvia (A.E.); Departments of Cardiology (C.Š.) and Imaging Methods (V.S.), Motol University Hospital, Prague, Czech Republic; Department of Cardiology, Medical Academy (G.Š.), and Department of Radiology (A.J.), Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia (N.Č.A., F.A.); Department of Cardiology, Institute for Cardiovascular Diseases of Vojvodina, Novi Sad, Serbia (N.Č.A., F.A.); Departments of Radiology (M.G.) and Cardiology (M.W.), University of Leipzig Heart Centre, Leipzig, Germany; Departments of Radiology (J.D.D.) and Cardiology (D.C.), St. Vincent's University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland (J.D.D.); Departments of Cardiology (I.D., A.R.) and Radiology (I.L.), Basurto Hospital, Bilbao, Spain; Departments of Cardiology (G.D.) and Radiology (E.T.), Aintree University Hospital, Liverpool, United Kingdom; Edge Hill University, Ormskirk, United Kingdom (G.D.); National Institute of Cardiology, Warsaw, Poland (C. Kępka, M.K.); Department of Cardiology, Internal Medicine Clinic, Clinical Hospital Center Zemun, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia (R.V., A.N.N.); Department of Radiological, Oncological and Pathological Sciences (M. Francone) and Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences (M. Mancone), Sapienza University of Rome, Rome, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy (M. Francone); Departments of Cardiology (M.I.S.) and Radiology (D.K.), Provincial Specialist Hospital in Wroclaw, Wroclaw, Poland; Departments of Internal Medicine III (F.P.), Cardiology (F.P.), and Radiology (G.F.), Innsbruck Medical University, Innsbruck, Austria; Turku PET Centre (J.K.) and Heart Center (M.P.), Turku University Hospital and University of Turku, Turku, Finland; Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia-Espinho, Vila Nova de Gaia, Portugal (R.F., V.G.R.); Department of Cardiology, Alb Fils Kliniken, Göppingen, Germany (S.S., T.D.); School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom (C.B., C.D.); Golden Jubilee National Hospital, Clydebank, United Kingdom (C.B.); Department of Cardiology, Liverpool University Hospital NHS FT, Liverpool, United Kingdom (B.R., M. Fisher); Institute for Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom (B.R., M. Fisher); European Clinical Research Infrastructure Network-European Research Infrastructure Consortium (ECRIN-ERIC), Paris, France (C. Kubiak); Department of Public Health, Section for Health Services Research, University of Copenhagen, Copenhagen, Denmark (K.S.H.); Bavarian Cancer Registry, Bavarian Health and Food Safety Authority, Munich, Germany (J.M.N.); Center of Advanced Research in Multimodality Cardiac Imaging, CardioMed Medical Center, Targu Mures, Romania (I.B., I.R.); Administrative Centre, Health Care District of Southwestern Finland, Turku, Finland (M.P.); Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom (M. Fisher); Department of Cardiology, Hillerød Hospital, University of Copenhagen, Copenhagen, Denmark (C. Kragelund); Department of Cardiology, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark (J.D.H.); Department of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark (L.L.); DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany (M. Mohamed, M.D.); Department of Clinical Epidemiology and Applied Biostatistics, Universitätsklinikum Tübingen, Tübingen, Germany (L.M.S.H., P.M.); Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany (H.D., M.D.); Department of Cardiology, Angiology and Intensive Care Medicine, Campus Charité Mitte, Berlin, Germany (H.D.); Department of Cardiology, Lundquist Institute at Harbor-UCLA, Torrance, Calif (M.J.B.); Berlin Institute of Health, Berlin, Germany (M.D.); and Berlin University Alliance, Berlin, Germany (M.D.).

Background Coronary artery calcium (CAC) has prognostic value for major adverse cardiovascular events (MACE) in asymptomatic individuals, whereas its role in symptomatic patients is less clear. Purpose To assess the prognostic value of CAC scoring for MACE in participants with stable chest pain initially referred for invasive coronary angiography (ICA). Materials and Methods This prespecified subgroup analysis from the Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) trial, conducted between October 2015 and April 2019 across 26 centers in 16 countries, focused on adult patients with stable chest pain referred for ICA.

View Article and Find Full Text PDF

Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.

Eur J Heart Fail

April 2024

Department of Cardiology, (CVK) and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.

Aims: Lower respiratory tract infections (LRTI) are common worldwide. Patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) have a high risk of developing LRTI. Prior studies were able to show that sodium-glucose cotransporter 2 inhibitors may reduce the incidence of LRTI in patients with type 2 diabetes.

View Article and Find Full Text PDF

Aim: Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA-125). The role of CA-125 as a biomarker of congestion or for prognosis across the full ejection fraction (EF) spectrum of chronic heart failure (HF) remains unknown.

Methods And Results: Serum CA-125 was measured in 1111 study participants from the EMPEROR-Reduced and EMPEROR-Preserved trials.

View Article and Find Full Text PDF

Importance: The effectiveness and safety of computed tomography (CT) and invasive coronary angiography (ICA) in different age groups is unknown.

Objective: To determine the association of age with outcomes of CT and ICA in patients with stable chest pain.

Design, Setting, And Participants: The assessor-blinded Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial was conducted between October 2015 and April 2019 in 26 European centers.

View Article and Find Full Text PDF

Delays have dangerous ends: Tuberculosis diagnosis delay in Portugal, a qualitative study.

Pulmonology

February 2024

EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal; Estudo das Populações, ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; Faculdade de Psicologia e Ciências da Educação, Universidade do Porto, Porto. Portugal.

View Article and Find Full Text PDF

Purpose: Physical exercise has positive effects on clinical outcomes of breast cancer survivors such as quality of life, fatigue, anxiety, depression, body mass index, and physical fitness. We aimed to study its impact on immune, inflammatory, cardiometabolic, and fatty acids (FA) biomarkers.

Methods: An exploratory sub-analysis of the MAMA_MOVE Gaia After Treatment trial (NCT04024280, registered July 18, 2019) was performed.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on identifying factors that contribute to prolonged survival in cancer patients admitted to palliative care, specifically those living over one year after admission.
  • - Researchers conducted a retrospective case-control study using electronic records from 2012 to 2018, comparing data from patients who survived over a year to those who survived 6 months or less, identifying 1721 total patients.
  • - Key findings indicated that higher hemoglobin levels and specific creatinine levels positively correlated with longer survival, while conditions like abnormal cognition and liver metastases were linked to shorter lifespans; further research is needed to confirm these results.
View Article and Find Full Text PDF

Effect of Body Mass Index on Effectiveness of CT versus Invasive Coronary Angiography in Stable Chest Pain: The DISCHARGE Trial.

Radiology

February 2024

School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (R.S., D.C., C.B., C.D.); Golden Jubilee National Hospital, Clydebank, United Kingdom (D.C., C.B.); Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M., P.M.H., T. Bárány, B.S., M.V.N.); Departments of Cardiology (K.F.K., A.D.K.) and Radiology (K.F.K., A.D.K.), Copenhagen University Hospital-Rigshospitalet & Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Southeastern Health and Social Care Trust, Belfast, United Kingdom (P.D., C.O., S. Kelly, S.R.); Department of Cardiology, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain (J.R.P., F.X.V., B.G.d.B.); Centro de Investigación Biomédica en Red, Madrid, Spain (J.R.P., F.X.V., B.G.d.B.); Department of Cardiology, Paul Stradins Clinical University Hospital, Riga, Latvia (A.E.); University of Latvia, Riga, Latvia (A.E.); Department of Cardiology, Motol University Hospital, Prague, Czech Republic (J.V., M.H.); Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania (G.Š.); Department of Cardiology, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania (G.Š.); Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia (N.Č.A., F.A.); Department of Cardiology, Institute for Cardiovascular Diseases of Vojvodina, Novi Sad, Serbia (N.Č.A., F.A.); Department of Radiology, University of Leipzig Heart Centre, Leipzig, Germany (M.G.); Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland (J.D.D.); School of Medicine, University College Dublin, Dublin, Ireland (J.D.D.); Department of Cardiology, Basurto Hospital, Bilbao, Spain (I.D., A.R.); Departments of Cardiology (G.D.) and Radiology (E.T.), Aintree University Hospital, Liverpool, United Kingdom; Edge Hill University, Ormskirk, United Kingdom (G.D.); Department of Radiology, Charité-Universitätsmedizin Berlin Campus Mitte, Charitéplatz 1, Freie Universität Berlin and Humboldt-Universität zu 10117 Berlin, Germany (E.Z., S.F., M. Mohamed, M.R., V.W., M.E., M.B., M.D.); National Institute of Cardiology, Warsaw, Poland (C. Kępka, M.K.); Department of Cardiology, Internal Medicine Clinic, Clinical Hospital Center Zemun, Belgrade, Serbia (R.V., A.Z.); Faculty of Medicine, University of Belgrade, Belgrade, Serbia (R.V.); Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy (M. Francone); Department of Biomedical Sciences, Humanitas University, Milan, Italy (M. Francone); Department of Cardiology, Provincial Specialist Hospital in Wroclaw, Wroclaw, Poland (M.I.S.); Department of Internal Medicine III, Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria (F.P.); Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland (J.K.); Department of Cardiology, Centro Hospitalar de Vila Nova de Gaia-Espinho, Vila Nova de Gaia, Portugal (R.F., V.G.R.); Department of Cardiology, Alb Fils Kliniken, Göppingen, Germany (S.S., T.D.); Department of Radiology, University of Cagliari, Cagliari, Italy (L.S.); Department of Cardiology, Royal Liverpool University Hospital, Liverpool, United Kingdom (B.R., M. Fisher); Institute for Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom (B.R., M. Fisher); Institute of Public Health, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (N.R.); ECRIN-ERIC (European Clinical Research Infrastructure Network-European Research Infrastructure Consortium), Paris, France (C. Kubiak); Department of Public Health, Section for Health Services Research, University of Copenhagen, Copenhagen, Denmark (K.S.H.); Bavarian Cancer Registry, Bavarian Health and Food Safety Authority, Munich, Germany (J.M.N.); Department of Radiology, Medical Imaging Center, Semmelweis University, Budapest, Hungary (P.M.H.); Center of Advanced Research in Multimodality Cardiac Imaging, CardioMed Medical Center, Targu Mures, Romania (I.B., I.R.); Department of Radiology, Paul Stradins Clinical University Hospital, Riga, Latvia (L.Z.); Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania (A.J.); Department of Radiology, Kaunas Clinics, Kaunas, Lithuania (A.J.); Department of Cardiology, University of Leipzig Heart Centre, Leipzig, Germany (M.W.); Department of Cardiology, St. Vincent's University Hospital, University College Dublin, Dublin, Ireland (S. Keane); Department of Radiology, Basurto Hospital, Bilbao, Spain (I.L.); Department of Cardiology and Angiology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (M.L., H.D.); Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy (M. Mancone); Department of Radiology, Provincial Specialist Hospital in Wroclaw, Wroclaw, Poland (D.K.); Department of Radiology, Innsbruck Medical University, Innsbruck, Austria (G.F.); Heart Center, Turku University Hospital and University of Turku, Turku, Finland (M. Pietilä); Administrative Centre, Health Care District of Southwestern Finland, Turku, Finland (M. Pietilä); Department of Radiology, University of Cagliari, Cagliari, Italy (M. Porcu); Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom (M. Fisher); Department of Cardiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark (C.S.); Department of Cardiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, Tirgu Mures, Romania (R.A.); Section of Cardiology, Department of Medicine, Copenhagen University Hospital of Glostrup, Glostrup, Denmark (J.A.); Department of Radiology, Hospital Universitario Vall d'Hebron, Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain (H.C.C.); Department of Cardiology, Nordsjaellands Hospital, Hillerod, Denmark (B.J.); Department of Internal Medicine, Clinic of Cardiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania (R.H., T. Benedek); DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany; Berlin Institute of Health, Berlin, Germany (H.D., M.D.); Berlin University Alliance, Berlin, Germany (M.D.); Department of Clinical Epidemiology and Applied Biostatistics, Universitätsklinikum Tübingen, Tübingen, Germany (L.M.S.H., P.M.); Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (K.N.); Oregon Health & Science University, Portland, Ore (M. Ferencik); County Clinical Emergency Hospital Targu Mures, Targu Mures, Romania (T. Benedek); Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany (M.D.); and Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany (M.D.).

Background Recent trials support the role of cardiac CT in the evaluation of symptomatic patients suspected of having coronary artery disease (CAD); however, body mass index (BMI) has been reported to negatively impact CT image quality. Purpose To compare initial use of CT versus invasive coronary angiography (ICA) on clinical outcomes in patients with stable chest pain stratified by BMI category. Materials and Methods This prospective study represents a prespecified BMI subgroup analysis of the multicenter Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) trial conducted between October 2015 and April 2019.

View Article and Find Full Text PDF

Actinomycosis is a chronic, suppurative, granulomatous bacterial infection primarily associated with . The condition can be categorized into three distinct clinical types based on the affected anatomical region: cervicofacial, pulmonary, or abdominopelvic actinomycosis. The standard treatment for actinomycosis involves antibiotic therapy, with an empiric penicillin regimen as the first-line approach.

View Article and Find Full Text PDF

Thoracic duct embolization has been increasingly adopted as a first-line therapy of chylothorax and this procedure includes lipiodol lymphangiography, thoracic duct access and embolization. Lymphangiography itself has a therapeutic role, with volume-dependent success rates of 37%-97% and even a reported 100% success rate in outputs of < 500 mL/day. We present a clinical case of a 48-years-old man diagnosed with esophageal squamous cell carcinoma, who underwent esophagectomy and presented with post-operative high-output (> 1L/day) chylothorax; thoracic duct embolization was proposed.

View Article and Find Full Text PDF

Purpose: Since the beginning of 2023, ChatGPT emerged as a hot topic in healthcare research. The potential to be a valuable tool in clinical practice is compelling, particularly in improving clinical decision support by helping physicians to make clinical decisions based on the best medical knowledge available. We aim to investigate ChatGPT's ability to identify, diagnose and manage patients with otorhinolaryngology-related symptoms.

View Article and Find Full Text PDF

Spinal cord injury without radiographic abnormality is a condition primarily observed in the pediatric population. However, its occurrence in adults remains underreported. This case report aims to describe a rare instance of adult spinal cord injury without neuroimaging abnormality (SCIWNA) following a road accident in a 52-year-old woman, emphasizing the clinical nuances and management challenges associated with this condition.

View Article and Find Full Text PDF

Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study.

Br J Anaesth

April 2024

Department of Anaesthesiology, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Article Synopsis
  • The 2022 European Society of Cardiology guidelines for preoperative evaluations aimed to improve the detection of pathological findings compared to the 2014 guidelines.
  • A study analyzed data from 15,529 patients and found that the updated recommendations changed testing protocols for many, but did not enhance the overall effectiveness of cardiac testing.
  • The use of B-type natriuretic peptide (NT-proBNP) for risk estimation did not improve pathological findings, and adherence to the new guidelines showed no significant link to major adverse cardiovascular events.
View Article and Find Full Text PDF